Jessica Chubak, PhD

“My research focuses on improving cancer control by finding effective ways to get screened for cancer and to navigate treatment and survivorship.”

Jessica Chubak, PhD

Senior Investigator, Kaiser Permanente Washington Health Research Institute

Biography

Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Based on a personal interest in how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies. She is the Kaiser Permanente Washington Health Research Institute (KPWHRI) principal investigator for the National Cancer Institute's Cancer Research Network.

Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington. Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the University of Washington School of Public Health where she enjoys guest lecturing and getting to work with students. 

Research interests and experience

  • Cancer

    Epidemiology; colorectal cancer; medication use; survivorship; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship

  • Health Services & Economics

    Chronic illness management; translation of preventive care research into clinical practice

  • Medication Use & Patient Safety

    Cancer risk and use of common medications; pharmaceutical outcomes research; validation of pharmacy data resources

 

Recent publications

Pocobelli G, Yu O, Ziebell RA, Aiello Bowles EJ, Fujii MM, Sterrett AT, Boggs JM, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Chubak J. Use of antidepressants after colon cancer diagnosis and risk of recurrence. Psychooncology. 2019 Jan 31. doi: 10.1002/pon.5015. [Epub ahead of print]. PubMed

Mayer SE, Weiss NS, Chubak J, Doody DR, Carlson CS, Makar KW, Wurscher MA, Malone KE. CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. LID - 10.1007/s10552-018-1117-x [doi] Cancer Causes Control. 2018 Dec 12. pii: 10.1007/s10552-018-1117-x. doi: 10.1007/s10552-018-1117-x [Epub ahead of print] PubMed

Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of colonoscopy following diagnosis of advanced adenomas: an analysis within integrated healthcare delivery systems. lid - 10.1158/1055-9965.epi-18-0452 [doi] Cancer Epidemiol Biomarkers Prev. 2018 Nov 20. pii: 1055-9965.EPI-18-0452. doi: 10.1158/1055-9965.EPI-18-0452 [Epub ahead of print] PubMed

Chen Y, Wang J, Chubak J, Hubbard RA. Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: empirical illustration using breast cancer recurrence. Pharmacoepidemiol Drug Saf. 2018 Oct 30. doi: 10.1002/pds.4680. [Epub ahead of print]. PubMed

 

innovating care

How to maximize screening for colon cancer

Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.

Read about it in News and Events.

Cancer Research

Research funded to improve cancer screening

Drs. Kamineni and Chubak are among leaders of 2 new large PROSPR awards from NCI for cervical and colorectal cancer screening research.

Read it in News and Events

Recent News

Therapy-dog visits for kids with cancer: A safe way to induce smiles?

Being in the hospital is stressful. A new KPWHRI study will see if visits from therapy dogs make the experience easier for pediatric cancer patients.

Read it in News and Events.